An innovative surgical adhesive from technology developed at the University of Pittsburgh by McGowan Institute faculty members Drs. Eric Beckman and Michael Buckley has been awarded a US patent. The technology provides a platform for strong, resorbable adhesives for use inside the body. The technology is marketed by Cohera Medical, Inc.
Cohera's first product, TissuGluTM, is currently in pre-clinical testing and is designed to adhere tissues to prevent fluid accumulation in deep wounds. Cohera has also won a Phase 1 SBIR Award for the design and development of a bioresorbable bone adhesive for orthopedic use. This award, for ~$130,000, is the company's second SBIR award this year. Dr. Beckman, Chief Scientific Officer and Co-Founder of Cohera Medical, will serve as the Principal Investigator on the study.
"The grant of Cohera's first patent reinforces the novelty of our core technology platform, and adds significant value to the company. The SBIR award further reinforces the breadth and potential for a variety of products that meet surgeons' needs across many specialties," said Patrick Daly, President and CEO of Cohera Medical.
Illustration: Cohera Medical, Inc.
Cohera Medical, Inc. (08/02/07)